drugset / Trial / NCT06044974

Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder.

NCT06044974

Phase 4 Completed 29 enrolled Alexandria University
RandomizedParallel-groupSingle-blindTreatment

Summary

A clinical trial comparing the potential effect of 2 different modalities (Nd-YAG Laser Versus Epidermal growth factor injection) on pain reduction in patients suffering from myogenic tempromandibular disorder.

Timeline

Start
2023-01-21
Primary completion
2023-08-10
Completion
2024-01-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator NEPIDERMIN Protein / enzyme biologic 0.1 ml